International Cannabis Weekly: 66

• UK to reschedule cannabis for medical use on November 1st.
• Cannabis Europa will pave the way for the development of European medical cannabis.
• UK Royal College of Psychiatrists to review its opposition to the legalisation of cannabis.
• GW Pharma raises €300 million on stock exchange.
• The Netherlands continues to lag behind in the emerging cannabis sector.
• CLV Frontiers’ cannabis-inspired terpene beers launch in London.
• Wayland successfully exports THC distillate from Canada to Switzerland.

• Latin America’s legal cannabis industry set to be worth $12.7 billion by 2028.
• Jamaica ships cannabis oil to Canada ahead of recreational legalisation.
• Tilray acquires Chilean distribution partner Alef Biotechnology.

• MGC Pharma teams up with Canadian cannabis investment company Cannaglobal.
• Little Green Pharma begins selling medical cannabis to patients.
• New Zealand Police Association conference focuses on recreational cannabis.
• Helius Therapeutics leases facility to produce medical cannabis in New Zealand.
• Australian company Roto-Gro International wraps up €4 million in funding.

• China’s Wuhan General Group is set to acquire MJ MedTech.
• Cannabis legislation is nearing completion in St. Vincent and the Grenadines.
• Canopy Growth completes first legal import of cannabis for research to the US.
• Aurora Cannabis to list on the New York Stock Exchange by end of October.
• North American cannabis legalisation has largely been a success.

• Trait develops technology to make cannabis beverages work as fast as alcohol.
• Comparative study examines extraction processes for hemp seed oil.
• US survey finds a majority of people would try recreational cannabis if it was legal.
• Consumer spending data projects growth in demand for legal cannabis.
• The future of medical cannabis is personalisation.

Prohibition Partners is pleased to announce the release of The LATAM Cannabis Report™. The report explores the medical, recreational, and industrial cannabis industries across the $12.7 billion market. The report is the most comprehensive review of the industry to date, identifying the regulatory guidelines and analysing market data across 11 LATAM states